Helicos Biosciences (NASDAQ: [[ticker:HLCS]]), the maker of tools for genetic researchers, said today it has promoted Steve Lombardi to CEO. Lombardi, 53, joined the company in October 2007 as president and chief operating officer. He takes over for Stan Lapidus, 59, who will remain chairman of the company’s board. We profiled Lombardi, a veteran of Applied Biosystems and Affymetrix, last month, when he said he was thinking about expanding the company’s manufacturing base in Massachusetts because of Gov. Deval Patrick’s 10-year, $1 bilion life sciences initiative.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
